-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Acute lymphocytic leukemia (ALL) is a common childhood cancer
Mitochondrial activated kinase MAP2K7 is a new target for anticancer drug therapy
The only downstream substrate of MAP2K7 is JNK.
The compound 5Z-7-oxozeaenol (5Z7O) can bind to the cysteine-218 position of MAP2K7, although it can also inhibit other kinases such as TAK1
The Lacorazza research team at Baylor College of Medicine mentioned in their Oncotarget study summary: “We have provided proof-of-principle data to support the targeting of the MAP2K7 pathway in children’s T-ALL